Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens.
about
Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C.Financial Incentives for Adherence to Hepatitis C Virus Clinical Care and Treatment: A Randomized Trial of Two Strategies.GSK2878175, a pan-genotypic non-nucleoside NS5B polymerase inhibitor, in healthy and treatment-naïve chronic hepatitis C subjects.Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis.Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection.The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study
P2860
Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adherence to treatment of chro ...... n and ribavirin free regimens.
@en
Adherence to treatment of chro ...... n and ribavirin free regimens.
@nl
type
label
Adherence to treatment of chro ...... n and ribavirin free regimens.
@en
Adherence to treatment of chro ...... n and ribavirin free regimens.
@nl
prefLabel
Adherence to treatment of chro ...... n and ribavirin free regimens.
@en
Adherence to treatment of chro ...... n and ribavirin free regimens.
@nl
P2093
P2860
P1433
P1476
Adherence to treatment of chro ...... n and ribavirin free regimens.
@en
P2093
Fatema Nader
Linda Henry
Maria Stepanova
Sharon Hunt
Youssef Younossi
Zobair M Younossi
P2860
P356
10.1097/MD.0000000000004151
P407
P577
2016-07-01T00:00:00Z